Telix Pharmaceuticals is trading at A$15.73, up 4.31%, with broader biotech-sector gains the likeliest explanation, though no direct company-specific catalyst was confirmed.
- Price is based on the October 16, 2026 close; the next ASX session is October 19.
- The October 14 announcement previewed 20 abstracts for the October 17–21 EANM congress; available coverage does not establish it as the cause of the rise.
- Trading volume and Monday’s price movement are not yet confirmed.